DNA%2520Strand_edited_edited.jpg
iBodylogo

LIGHTNING ANTIBODY DISCOVERY

iBody Inc. is a startup company from Nagoya University, Japan.

We will contribute to the improvement of human health and QOL by developing new antibody therapeutics using our unique technology "Ecobody " that can discover natural human antibodies from the human body.

News

14 Jun 2021

Patent Registered in US

A patent, about our core technology for antibody protein production in cell-free protein synthesis system or microorganism, has been registered in US. We have exclusive license agreement of this technology globally with Nagoya University.

U.S. Patent Number: 10975376

Title: PROTEIN EXPRESSION METHOD

1 Jun 2021

Adopted for "New Aichi Creative Research and Development Subsidy 2021"

Our project was adopted for "New Aichi Creative Research and Development Subsidy 2021" which Aichi Prefecture supports research and development conducted by companies in fields where future growth is expected, such as next-generation automobiles, aerospace, environment and new energy.

4 Feb 2021

Participation in 2nd Kyoto University Life Science Showcase @ San Diego 2021

We will present at 2nd Kyoto University Life Science Showcase @ San Diego 2021 which is an online showcase event held on March 3.

25 Sep 2020

Participation in BioJapan 2020

We will participate in BioJapan2020 held in Pacifico Yokohama from 14th to 16th October 2020.

Booth : D-29,Organization for Small & Medium Enterprises and Regional Innovation, JAPAN

25 Jan 2021

Selected as a member of J-startup CENTRAL

We were selected as one of twenty companies of “J-Startup CENTRAL” which was organized to support start-up companies aiming for global success by Aichi/Nagoya area, Hamamatsu City and Ministry of Economy, Trade and Industry (METI).